Dr. Wangpaichitr’s area of expertise is focused on tumor metabolism and mechanisms of drug resistance, as well as on the development of new tumor models for clinical use. He is currently an Associate Professor at the University of Miami, Department of Surgery/Division of Cardiothoracic Surgery. He also holds a full-time appointment in the Research Service at the Miami VA Healthcare System as a Research Scientist. He demonstrated that cisplatin- or carboplatin-resistant (CR) lung cancer cells possess higher levels of reactive oxygen species (ROS) when compared with parental cell counterparts, leading to metabolic reprogramming from glycolytic to oxidative metabolism.